Exploring predictive molecules of acute adverse events in response to volumetric‑modulated arc therapy for prostate cancer using urinary metabolites-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exploring predictive molecules of acute adverse events in response to volumetric‑modulated arc therapy for prostate cancer using urinary metabolites

Published:2024-07-09 Issue:3 Volume:21 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Obara Hideki¹,Tatara Yota²,Monzen Satoru³,Murakami Sho¹,Yamamoto Hiroki¹,Kimura Naoki¹,Suzuki Masashi¹,Komai Fumio¹,Narita Masataka¹,Hatayama Yoshiomi¹,Aoki Masahiko¹

Affiliation:

1. Department of Radiology, Hirosaki University Hospital, Hirosaki, Aomori 036‑8563, Japan

2. Department of Stress Response Science, Biomedical Research Center, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036‑8562, Japan

3. Department of Radiation Science, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori 036‑8564, Japan

Publisher

Spandidos Publications

Reference31 articles.

1. Radiation therapy for prostate cancer;Iwamoto;Semin Oncol Nurs,2001

2. Incidence of genitourinary complications following radiation therapy for localized prostate cancer;David;World J Urol,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP